Seeking Alpha3 小时
Genmab A/S: Circling Back On This Complicated Story
As stated in the prior report, the company’s poor stock price performance at that time (down 37% since approaching an ...
来自MSN8 小时
Regeneron Down 15.5% Year to Date: How to Play the Stock?
Shares of Regeneron Pharmaceuticals, Inc. REGN have dropped 15.5% in the year so far compared with the industry’s decline of ...